1. Home
  2. ELTX vs LODE Comparison

ELTX vs LODE Comparison

Compare ELTX & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • LODE
  • Stock Information
  • Founded
  • ELTX 2011
  • LODE 2008
  • Country
  • ELTX United States
  • LODE United States
  • Employees
  • ELTX N/A
  • LODE N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • ELTX Health Care
  • LODE Industrials
  • Exchange
  • ELTX Nasdaq
  • LODE Nasdaq
  • Market Cap
  • ELTX 158.5M
  • LODE 168.0M
  • IPO Year
  • ELTX N/A
  • LODE N/A
  • Fundamental
  • Price
  • ELTX $9.15
  • LODE $3.63
  • Analyst Decision
  • ELTX Strong Buy
  • LODE Hold
  • Analyst Count
  • ELTX 1
  • LODE 1
  • Target Price
  • ELTX $13.00
  • LODE $4.00
  • AVG Volume (30 Days)
  • ELTX 110.4K
  • LODE 968.9K
  • Earning Date
  • ELTX 11-13-2025
  • LODE 10-30-2025
  • Dividend Yield
  • ELTX N/A
  • LODE N/A
  • EPS Growth
  • ELTX N/A
  • LODE N/A
  • EPS
  • ELTX N/A
  • LODE N/A
  • Revenue
  • ELTX N/A
  • LODE $2,778,445.00
  • Revenue This Year
  • ELTX N/A
  • LODE $7.65
  • Revenue Next Year
  • ELTX N/A
  • LODE $1,093.72
  • P/E Ratio
  • ELTX N/A
  • LODE N/A
  • Revenue Growth
  • ELTX N/A
  • LODE 48.99
  • 52 Week Low
  • ELTX $4.60
  • LODE $1.67
  • 52 Week High
  • ELTX $12.62
  • LODE $10.10
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 51.67
  • LODE 61.43
  • Support Level
  • ELTX $7.87
  • LODE $3.04
  • Resistance Level
  • ELTX $8.99
  • LODE $3.61
  • Average True Range (ATR)
  • ELTX 0.53
  • LODE 0.25
  • MACD
  • ELTX 0.08
  • LODE 0.07
  • Stochastic Oscillator
  • ELTX 82.72
  • LODE 96.62

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About LODE Comstock Inc.

Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.

Share on Social Networks: